SMAD3 and colonic neoplasm: Additionally, rAF-IL12 was shown to also increase the expression level of Smad3, which is known to be involved in inhibiting survival, proliferation, and tumorigenesis in colon cancer in response to transforming growth factor-β (TGF-β) stimulation.